Medtronic plc (MDT)
Market Closed
16 Oct, 08:00 PM
$
94. 75
-0.7
-0.7334%
$
122.1B Market Cap
25.14 P/E Ratio
2.84% Div Yield
30.27M Volume
5.2 Eps
$ 95.45
Previous Close Want to track MDT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
MDT closed yesterday lower at $94.75, a decrease of -0.7334% from Thursday's close, completing a monthly increase of 0.7979% or $0.75. Over the past 12 months, MDT stock lost -1.2712%.
MDT pays dividends to its shareholders, with the most recent payment made on Oct 16, 2026. The next estimated payment will be in In 2 months on Jan 16, 2027 for a total of $0.72.
The last earnings report, released on May 20, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0267%, based on the last three reports.
Medtronic plc has completed 7 stock splits, with the recent split occurring on Sep 27, 1999.
The company's stock is traded on 14 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Is it Apt to Retain Medtronic Stock in Your Portfolio Now?
MDT expands in cardiac ablation, robotics, hypertension and digital surgery, but tariff, inflation and currency risks are likely to pressure margins.
Zacks | 2 days ago
Medtronic Pays More Today. Abbott Raises Its Dividend Faster.
Both are Dividend Kings with decades of consecutive raises, but Medtronic and Abbott reward income investors in fundamentally different ways, and choosing the wrong one in retirement could cost you more than you expect.
247wallst | 4 days ago
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
Medtronic (MDT) closed at $93.01 in the latest trading session, marking a +1.17% move from the prior day.
Zacks | 4 days ago
Medtronic plc Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 75,385 | $6.4M | $7.2M | $799,240.36 | 12.5% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 1,165 | $99,988.31 | $110,383.75 | $10,395.44 | 10.4% |
 Michelle S. Hickox FIRST FINANCIAL BANKSHARES Inc. | 752,965 | $62.87M | $71.57M | $8.69M | 13.83% |
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 1,046 | $89,502.92 | $99,113.73 | $9,610.81 | 10.74% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 12,062 | $1.24M | $1.14M | -$95,407.58 | -7.72% |
Medtronic plc (MDT) FAQ
What is the stock price today?
The current price is $94.75.
On which exchange is it traded?
Medtronic plc is listed on NYSE.
What is its stock symbol?
The ticker symbol is MDT.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2.84%.
What is its market cap?
As of today, the market cap is 122.1B.
Has Medtronic plc ever had a stock split?
Medtronic plc had 7 splits and the recent split was on Sep 27, 1999.
Medtronic plc Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Geoffrey Straub Martha CEO | NYSE Exchange | G5960L103 CUSIP |
| IE Country | 95,000 Employees | 25 Sep 2026 Last Dividend | 27 Sep 1999 Last Split | 13 Jan 1978 IPO Date |
Overview
Medtronic plc is a global leader in medical technology, specializing in the development, manufacture, and sale of device-based medical therapies. Serving healthcare systems, physicians, clinicians, and patients around the world, the company is dedicated to alleviating pain, restoring health, and extending life for millions of people. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic operates across various medical domains through its diverse portfolio which includes cardiovascular, medical surgical, neuroscience, and diabetes treatments and technologies.
Products and Services
Medtronic’s comprehensive range of products and services is categorized into four primary segments:
- Cardiovascular Portfolio: This segment offers advanced device-based solutions for cardiac care, including:
- Implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices for heart rhythm management.
- Cardiac ablation products for treating atrial fibrillation.
- Insertable cardiac monitor systems for continuous heart monitoring.
- TYRX products, which involve antimicrobial envelopes for electronic implantable devices.
- Aortic valves, surgical valve replacement and repair products, transcatheter pulmonary valves, and endovascular stent grafts for structural heart disease treatment.
- Percutaneous coronary intervention products and angioplasty balloons for coronary artery disease treatment.
- Remote monitoring and patient-centered software for enhanced patient care.
- Medical Surgical Portfolio: This segment encompasses a broad array of surgical instruments and devices, including:
- Surgical stapling devices and vessel sealing instruments for precise surgical procedures.
- Wound closure products and electrosurgery products aimed at efficient surgical recovery.
- Surgical artificial intelligence and robotic-assisted surgery products for advanced surgical techniques.
- Hernia mechanical devices and mesh implants, along with other gynecology and lung health products.
- Minimally invasive gastrointestinal and hepatologic diagnostic and therapy tools, patient monitoring, airway management and ventilation therapies, and renal disease treatments.
- Neuroscience Portfolio: This segment delivers solutions for the central nervous system and supportive structures, including:
- Products for spinal, neuro, and orthopedic surgeries, pain management, and urology.
- Energy surgery instruments and image-guided surgery systems for enhanced surgical accuracy.
- Intra-operative imaging and robotic guidance systems for spine procedures.
- Therapies for brain vasculature conditions.
- Diabetes Operating Unit: Focused on diabetes management, this segment offers:
- Insulin pumps and consumables for continuous insulin delivery.
- Continuous glucose monitoring systems for real-time blood glucose tracking.
- Smart insulin pen systems and related consumables for modern diabetes care.
Contact Information
Address: Building Two, Parkmore Business Park West
Phone: 353 1 438 1700
Website: https://www.medtronic.com
2026 © Marketlog. All Rights Reserved.
